Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Te Ling

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2010
Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapyBo-Ying Bao, Jiunn-Bey Pao, Chun-Nung Huang, et al.
International Journal of Molecular Sciences|March 6, 2021
Human Costars Family Protein ABRACL Modulates Actin Dynamics and Cell Migration and Associates with Tumorigenic GrowthBo-Yuan Hsiao, Chia-Hsin Chen, Ho-Yi Chi, et al.
Cancer Cell International|April 19, 2019
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progressionChia-Cheng Yu, Lih-Chyang Chen, Chih-Yung Chiou, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 11, 2010
Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the diseaseBo-Ying Bao, Jiunn-Bey Pao, Victor C Lin, et al.
Annals of Surgical Oncology|March 6, 2010
Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancerBo-Ying Bao, Victor C Lin, Shu-Hung Huang, et al.
Oncotarget|November 2, 2017
Vitamin D receptor-binding site variants affect prostate cancer progressionVictor C Lin, Shu-Pin Huang, Huei-Ju Ting, et al.
BJU International|August 26, 2010
Clinical significance of runt-related transcription factor 1 polymorphism in prostate cancerShu-Pin Huang, Yu-Hsuan Lan, Te-Ling Lu, et al.
International Journal of Medical Sciences|September 21, 2016
Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical ProstatectomyCheng-Hsueh Lee, Jiunn-Bey Pao, Te-Ling Lu, et al.
American Journal of Cancer Research|February 7, 2024
Identifying the role of MTHFD1L in prostate cancer progression from genetic analysis and experimental validationYuan-Chin Tsai, Shu-Pin Huang, Wei-Chung Cheng, et al.
Blood|August 15, 2019
Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesisTe Ling, Yehudit Birger, Monika J Stankiewicz, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2010
Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapyBo-Ying Bao, Jiunn-Bey Pao, Chun-Nung Huang, et al.
International Journal of Molecular Sciences|March 6, 2021
Human Costars Family Protein ABRACL Modulates Actin Dynamics and Cell Migration and Associates with Tumorigenic GrowthBo-Yuan Hsiao, Chia-Hsin Chen, Ho-Yi Chi, et al.
Cancer Cell International|April 19, 2019
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progressionChia-Cheng Yu, Lih-Chyang Chen, Chih-Yung Chiou, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 11, 2010
Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the diseaseBo-Ying Bao, Jiunn-Bey Pao, Victor C Lin, et al.
Annals of Surgical Oncology|March 6, 2010
Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancerBo-Ying Bao, Victor C Lin, Shu-Hung Huang, et al.
Oncotarget|November 2, 2017
Vitamin D receptor-binding site variants affect prostate cancer progressionVictor C Lin, Shu-Pin Huang, Huei-Ju Ting, et al.
BJU International|August 26, 2010
Clinical significance of runt-related transcription factor 1 polymorphism in prostate cancerShu-Pin Huang, Yu-Hsuan Lan, Te-Ling Lu, et al.
International Journal of Medical Sciences|September 21, 2016
Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical ProstatectomyCheng-Hsueh Lee, Jiunn-Bey Pao, Te-Ling Lu, et al.
American Journal of Cancer Research|February 7, 2024
Identifying the role of MTHFD1L in prostate cancer progression from genetic analysis and experimental validationYuan-Chin Tsai, Shu-Pin Huang, Wei-Chung Cheng, et al.
Blood|August 15, 2019
Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesisTe Ling, Yehudit Birger, Monika J Stankiewicz, et al.
Pageof 12